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Introduction
Recent reports have shown that vitamin D deficiency is
widespread in both developed and developing countries.
Nearly 1 billion people around the world appear to be
suffering from vitamin D deficiency or insufficiency.1 The
problem is more serious in Pakistan where 86% of the
adults have been reported to be suffering from vitamin D
deficiency with levels of 25 hydroxy(OH) vitamin D3
[25(OH)D] less than 20 ng/ml,2 while 97% of females in a
community based-population in Karachi were found to
have insufficient vitamin D with levels of 25(OH)D less than
30 ng/ml.3 There is some evidence to suggest that there is
a relationship of plasma levels of 25(OH)D and phenotypes
of vitamin D binding protein (VDBP) which is a major
transporter of vitamin D3 and its metabolites and is also
known as a group-specific (Gc) protein.4 This is indicative of
a role of VDBP gene polymorphism in determining serum
concentrations of vitamin D3 in certain populations.4,5
Type 2 diabetes mellitus (T2DM) is one of the major
threats to human health in Pakistan.  The prevalence of
T2DM in Pakistan has been reported to be 6% in men and
3.5% in women in urban areas,6 and because of changing
lifestyle, it has been estimated that by the year 2035
Pakistan will be ranked 8th in the world in terms of the
number of diabetic patients.7
A few recent studies have demonstrated an association of
serum levels of 25(OH)D and risk of T2DM,8,9 suggesting
that the VDBP polymorphism could be playing some role
in the pathogenesis of T2DM.
Few reports show association between the VDBP
polymorphism and T2DM. The association has been
found mostly in non-Caucasians,10 while no relationship
has been reported in European White populations.11,12
To the best of our knowledge, no study has been carried
out to investigate the association of the VDBP
polymorphism with T2DM in a South Asian population.
The current study was planned to find out whether
genotypes/diplotypes of VDBP have any association with
T2DM, and to investigate any relationship of vitamin D
deficiency with T2DM.
Subjects and Methods
This case-control study was conducted from January 2013
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Abstract
Objective: To assess if genotypes/diplotypes of vitamin D binding protein have any association with type 2 diabetes
mellitus.
Methods: This case-control study was conducted from January 2013 to July 2015 at the endocrinology clinics of the
Aga Khan University Hospital, Karachi, and comprised adult patients with type 2 diabetes and their age- and gender-
matched healthy controls. Venous blood was obtained and assessed for serum/plasma 25 hydroxyvitamin D,
parathyroid hormone, calcium, alkaline phosphatase and creatinine. Deoxyribonucleic acid was isolated and
genotyping was done by polymerase chain reaction-restriction fragment length polymorphism procedures.
Results: Of the 330 participants, there were 165(50%) cases and as many controls. There were 116(70.3%) males and
49(29.7%) females in each group. The mean age of the patients was 48.82±9.23 years and that of the controls was
46.27±8.77 years (range: 22-70 years) (p=0.010) Mean serum concentration of 25 hydroxy vitamin D was significantly
higher among the patients compared to the controls (p<0.001), but not significantly different by genotypes or
diplotypes (p>0.05). Multiple conditional logistic regression revealed an association of group-specific 1-2 genotype
with patients when adjusted for age, body mass index, and serum levels of 25 hydroxy vitamin D with matched
adjusted odds ratio (95% confidence interval) being 3.1(1.22-7.88).
Conclusion: Group-specific 1-2 genotype of vitamin D binding protein gene was associated with the risk of type 2
diabetes.
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to July 2015 at the endocrinology clinics of the Aga Khan
University Hospital (AKUH), Karachi, and comprised adult
patients with T2DM. Similar number of gender and age-
matched (within 5 years) healthy controls were also
recruited from the personnel of AKUH and other 3
healthcare institutions in Karachi. The sample in each
group (T2DM patients and healthy controls) would
achieve a power of 80% and was based on the
assumption that the frequency of any of the 6 diplotypes
among healthy controls would range between 25% and
65%, anticipated matched odds ratio (OR) of 2.25 or more,
correlation coefficient of exposure between matched
case-control subjects = 0.2 and   a = 0.05.10 Patients
diagnosed with T2DM on the basis of guidelines set by
the International Diabetes Federation13 (fasting serum
glucose > 126mg/dl; clinical history), who were not taking
vitamin D supplements during the last 6 months, were
not suffering from tuberculosis, or liver disease, or
uraemia or cancer, and were not pregnant were included.
Similarly, healthy controls with no history of T2DM and
who were not having fasting serum glucose >110mg/dl
were included. They had not been taking vitamin D
supplements during the preceding 6 months and were
not suffering from any of the above-mentioned diseases
or conditions. Demographic characteristics of the two
groups were collected using a pre-structured
questionnaire after the study protocol was approved by
the institutional ethics review committee.
Then, 10ml of venous blood (with at least 4 hours of
fasting) was collected and transferred in equal volumes to
a tube containing ethylenediaminetetraacetic acid (EDTA)
and another with no anti-coagulant. Plasma/serum was
obtained and analysed for 25(OH)D, parathyroid hormone
(PTH), calcium, alkaline phosphatase (ALP), phosphate
and creatinine using kits following manufacturer's
instructions (Roche Diagnostics, Indianapolis, Indiana,
United States). The minimum detection limits of 25(OH)D,
PTH, calcium, ALP, phosphate and creatinine were 4
ng/ml, 1.2 pg/ml, 0.4 mg/dl, 3 U/l, 0.31 mg/dl and 0.2
mg/dl, respectively.
Genomic deoxyribonucleic acid (DNA) was extracted by
salting out method. VDBP(Gc) gene was amplified by
polymerase chain reaction (PCR) using the forward primer
(5 'TAAT-GAGCAAATGAAAGAAG3') and reverse primer (5
'TGAGTAGATTGGAGTGCATAC3') as described by Ito et
al.14 The amplified region is 462 base-pairs (bp) and it
covers point mutations rs7041and rs4588. A typical PCR
mixture contained 100ng DNA, 1xPCR buffer, 200mM
deoxyribonucleotides, 1.5mM magnesium chloride
(MgCl2), 1U Taq polymerase (Promega, Wisconsin, United
States) and 10 pM each of the primers in a total volume of
10 ml. The amplification conditions were 94ºC for 30sec,
56ºC for 30sec, 72ºC for 30sec for 35 cycles.
Genotypes were identified by restriction fragment length
polymorphism (RFLP). The PCR product was digested
separately by HaeIII and StyI-HFTM (New England Biolabs
Inc., Ipswich, Massachusetts) at 37ºC for 6 hours. Gc1F
remained uncut by both enzymes. GcIS was cut by HaeIII
only, resulting in 295bp and 167bp bands. Gc2 was
digested by StyI-HFTM into 302bp and 156bp bands. The
digested products were resolved on 3.0% agarose gel
containing 0.2 mg/ml ethidium bromide.
SPSS 19 was used for data analysis. Cross tabulations of Gc
gene (Gc genotypes, diplotypes and alleles) and the type
of subjects (cases and controls) were carried out to
observe the frequency distribution of Gc genotypes,
diplotypes and alleles in the two groups. Chi-square
goodness of fit test of deviation from Hardy-Weinberg
Equilibrium (HWE) was employed using trinomial
equation.15 Mean difference of 25(OH)D with respect toGc
genotypes and Gc diplotypes in the patients and controls
were compared using two-way analysis of variance
(ANOVA). Mean ± standard deviation (SD) values of other
quantitative variables such as age, body mass index (BMI),
25(OH)D, PTH, calcium, alkaline phosphatase, phosphate,
and creatinine in the two groups were compared using
paired samples t-test. McNemar's test was used for
assessing the significance of qualitative variables, such as
smoking, use of smokeless tobacco, sunlight exposure,
use of statins, hypertension, ischaemic heart disease
(IHD), hypercholesterolaemia, use of cooking oil/fat,
engagement in exercise, extent of physical activity and
vitamin D status. The relationship between Gc genotypes
and T2DM separately and when controlling for other
variables were assessed through simple and multiple
conditional logistic regression and reported as crude and
adjusted matched odds ratios with 95% confidence
interval (CI). A p<0.05 was considered significant.
Results
Of the 330 participants, there were 165(50%) in each of the
two groups. There were 116(70.3%) males and 49(29.7%)
females in each group. The mean age of the patients was
48.82±9.23 years and that of the controls was 46.27±8.77
years (range: 22-70 years) (p=0.010). Mean values of age
and BMI and serum/plasma concentrations of 25(OH)D
and alkaline phosphatase were significantly different in
T2DM patients compared to the controls (p<0.05). 
Proportions of statin users, hypertensives and those
having IHD and hypercholesterolaemia were significantly
higher in the patients compared to the controls (p<0.05).
Diabetics were more regular in physical exercise
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Table-1: Demographic and clinical characteristics of type 2 diabetes mellitus (DM) patients and healthy controls (Mean ± SD).
Variable                                                                                                                  Type 2 DM (n=165)                                                  Healthy controls(n=165)                                               p value*
Age (Years)                                                                                                                        48.82±9.23                                                                           46.27±8.77                                                                   0.010
BMI                                                                                                                                       28.96±4.13                                                                           25.24±3.45                                                                 <0.001
25(OH)D (ng/ml)                                                                                                              21.67±10.7                                                                           16.70±11.3                                                                 <0.001
PTH (pg/ml)                                                                                                                     38.96±16.77                                                                          37.35±24.9                                                                   0.395
Calcium (mg/dl)                                                                                                                9.37±1.66                                                                              9.40±1.30                                                                    0.850
Alkaline phosphatase (U/l)                                                                                          65.26±24.67                                                                         76.56±37.39                                                                 0.002
Phosphate (mg/dl)                                                                                                           3.62±0.63                                                                              3.68±0.64                                                                    0.395
Creatinine (mg/dl)                                                                                                            0.87±0.21                                                                              0.85±0.18                                                                    0.256
                                                                                                                                                   n(%)                                                                                       n(%)                                                                              
Smoking                                                                                                                                                                                                                                                                                                                          0.033
Never                                                                                                                                      116(70.3)                                                                                135(81.8)                                                                          
Current                                                                                                                                    25(15.2)                                                                                   13(7.9)                                                                             
Ever                                                                                                                                          24(14.5)                                                                                  17(10.3)                                                                            
Smokeless tobacco                                                                                                                                                                                                                                                                                                       0.763
User                                                                                                                                          23(13.9)                                                                                  25(15.2)                                                                            
Non-user                                                                                                                               142(86.1)                                                                                140(84.8)                                                                          
Sunlight exposure                                                                                                                                                                                                                                                                                                        0.216
Yes                                                                                                                                           61(37.0)                                                                                  50(30.3)                                                                            
No                                                                                                                                           104(63.0)                                                                                115(69.7)                                                                          
On statin medication                                                                                                                                                                                                                                                                                                 <0.001
Yes                                                                                                                                           89(53.9)                                                                                   13(7.9)                                                                             
No                                                                                                                                             76(48.1)                                                                                 152(92.1)                                                                          
Hypertension                                                                                                                                                                                                                                                                                                                <0.001
Yes                                                                                                                                           68(41.5)                                                                                  25(15.2)                                                                            
No                                                                                                                                            96(58.5)                                                                                 140(84.8)                                                                          
Ischaemic heart disease                                                                                                                                                                                                                                                                                             0.027
Yes                                                                                                                                             11(6.7)                                                                                      2(1.2)                                                                              
No                                                                                                                                           154(93.3)                                                                                163(98.8)                                                                          
Hypercholesterolaemia (> 200 mg/dl)                                                                                                                                                                                                                                                               <0.001
Yes                                                                                                                                           93(56.4)                                                                                   13(7.9)                                                                             
No                                                                                                                                             72(43.6)                                                                                 152(92.1)                                                                          
Use of cooking oil/fat                                                                                                                                                                                                                                                                                                  0.001
Vegetable oil                                                                                                                       114(69.1)                                                                                139(84.2)                                                                          
Vanspati ghee (hydrogenated oil)                                                                                 10(6.1)                                                                                     0(0.00)                                                                             
Both                                                                                                                                        41(24.8)                                                                                  26(15.8)                                                                            
Engagement in exercise                                                                                                                                                                                                                                                                                          <0.001
No                                                                                                                                            44(26.7)                                                                                 110(66.7)                                                                          
Once/week                                                                                                                            32(19.4)                                                                                  17(10.3)                                                                            
2-5 times/wk                                                                                                                        26(15.7)                                                                                   12(7.3)                                                                             
Daily                                                                                                                                        63(38.2)                                                                                  26(15.7)                                                                            
Extent of physical activity                                                                                                                                                                                                                                                                                           0.02
Less than 1 h/day                                                                                                                60(36.6)                                                                                  40(24.2)                                                                            
1-4 h/day                                                                                                                               62(37.8)                                                                                  61(37.0)                                                                            
> 4h/day                                                                                                                               42(25.6)                                                                                  64(38.8)                                                                            
Vitamin D status                                                                                                                                                                                                                                                                                                         <0.001
Deficient (< 20 ng/ml)                                                                                                     87(52.7)                                                                                 115(69.7)                                                                          
Insufficient (20-30 ng/ml)                                                                                               40(24.2)                                                                                  32(19.4)                                                                            
Sufficient (> 30 ng/ml)                                                                                                    38(23.1)                                                                                   18(10.9                                                                            
*Proportions in the two groups are compared using McNemar's test and simple conditional logistic regression, while mean values in patient and control groups are compared using Paired samples t-test.
BMI: Body mass index
25(OH)D: 25 hydroxy vitamin D
PTH: Parathyroid hormone
SD: Standard deviation.
compared to the controls, but significantly more controls
were engaged in daily routine physical activity (greater
than 4 hours per day) compared to the patients (p<0.05). 
Serum levels of 25(OH)D were significantly higher in the
patients compared to the controls (p<0.001) (Table-1).
The frequency distribution of alleles and genotypes was
in accordance with HWE (p=0.98 among cases and
p=0.99 among controls). Mean 25(OH)D levels were
significantly higher among the cases than the controls,
but not significantly different by genotypes or diplotypes
(Table-2). 
However, when the genotypes were compared using
conditional logistic regression model, Gc 1-2 was found to
be associated with T2DM. Matched, adjusted OR with 95%
CI was 3.10(1.22-7.88) when the model was adjusted for
age, BMI and serum levels of vitamin D (Table-3).
Discussion
Regarding the association of Gc gene polymorphism with
T2DM, there have been conflicting reports.  Hirai et al.
showed significantly decreased proportion of Gc 1F allele
in Japanese T2DM patients compared to Gc 1S and Gc 2
alleles.10 However, no association between genotypes
and haplotypes and T2DM could be found in Polish and
French Caucasian populations.11,12
In a recent meta-analysis, moderate association of Gc
gene polymorphism with increased susceptibility to
developing T2DM was found in three populations in
Japan and China.16 Apart from studies on these Asian
populations, no reports are available on the relationship
of Gc gene polymorphism and T2DM in South Asian
populations. Our results, therefore, are unique in
reporting this association with T2DM in a Pakistani
population. As against a modest association in other
Asian populations, the odds of having T2DM were more
than 3-fold in individuals with genotype Gc 1-2 compared
to genotype Gc 1-1 (the most common genotype).
The underlying mechanism of this association between
Gc genotypes and pathogenesis of T2DM is not clear at
this moment. Variations in Gc protein could be
influencing the serum levels of vitamin D metabolites,
which in turn could be affecting the insulin secretory
activity of pancreatic b cells.17
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Table-2: Distribution of frequencies of Gc genotypes and Gc diplotypes and mean levels of 25(OH)D in type 2 diabetes mellitus (DM) patients and healthy controls in a Pakistani
population.
Gc gene                   Type 2 DM patients (n=165)            Healthy  controls (n=165)                                                                                       p value*
                                  n(%)          Mean ± SD 25(OH)D         n(%)           Mean ± SD 25(OH)D                        Groups                         Genotypes/Diplotypes      Interaction between Groups
                                                                                                                                                                                                                                                                                                    & Genotypes/Diplotypes
Genotype                                                                                                                                                                 0.031(F=4.707;df 1, 324)        0.159(F=1.848,df 2, 324)            0.707(F=0.347,df 2,324)
Gc 1-1                   73(44.2)                  22.7±11.4                 91(55.2)                   17.5±12.6                                                                                                                                                                  
Gc 1-2                   82(49.7)                  21.4±10.3                 64(38.8)                     15.8±9.7                                                                                                                                                                   
Gc 2-2                    10(6.1)                    16.2±7.8                    10(6.1)                      14.9±9.0                                                                                                                                                                   
Diplotypes                                                                                                                                                                0.004(F=8.215,df 1,318)         0.291(F=1.239,df 5,318)            0.963(F=0.198,df 5,318)
1F-1F                       6(3.6)                   23.16±13.2                  3(1.8)                      15.4±13.3                                                                                                                                                                  
1S-1S                    46(27.9)                 22.37±11.5                61(37.0)                   17.3±11.5                                                                                                                                                                  
2-2                          10(6.1)                    16.2±7.8                    10(6.1)                      14.9±9.0                                                                                                                                                                   
1F-1S                    21(12.7)                  23.3±11.1                 27(16.4)                   18.1±15.1                                                                                                                                                                  
1F-2                       24(14.5)                  24.3±10.1                 18(10.9)                     17.4±8.2                                                                                                                                                                   
1S-2                      58(35.2)                  20.2±10.2                 46(27.9)                   15.2±10.2                                                                                                                                                                  
*p value compares mean levels of 25(OH)D by Two way ANOVA. Groups are type 2 DM patients and healthy controls
Gc: Group-specific
DM: Diabetes mellitus
25(OH)D: 25 hydroxy vitamin D.
Table-3: Association of Gc genotypes with type 2 diabetes mellitus in a Pakistani
population.
Genotype                                   Crude MOR (95% CI)a                               MAOR (95% CI)b
Gc 1-1c                                                               1.0                                                                  1.0
Gc 1-2                                                   1.64 (1.03-2.62)                                        3.10(1.22-7.88)
Gc 2-2                                                   1.16 (0.48-2.83)                                       2.98(0.43-20.66)
aMatched odds ratio (95% confidence interval).
bMatched adjusted odds ratio when the model was adjusted for age, BMI and serum levels of
vitamin D.
cMost common genotype of Gc gene was taken as reference
Gc: Group-specific
MOR: Matched odds ratios
MAOR: Matched adjusted odds ratio
CI: Confidence interval.
Pittas et al. have reported an association between low
serum levels of vitamin D and type 2 DM.18 However, our
results showed no such association between serum levels
of 25(OH)D and T2DM. Similar findings have been
reported in a study from Western India, showing no
relationship between vitamin D deficiency and T2DM in
Indian population.19 It appears that in the presence of very
high prevalence of hypovitaminosis D in both T2DM
patients and healthy controls in South Asian populations,
including Pakistanis, any relationship of vitamin D
deficiency with pathogenesis of T2DM is likely to remain
inconclusive. Lauridsen et al.20 have shown that serum
concentration of vitamin D metabolites is highest in Gc 1-
1, intermediate in Gc 1-2 and lowest in Gc 2-2. The same
trend has been observed in the present study with respect
to concentrations of 25(OH)D in individuals with these 3
genotypes in both T2DM and healthy control groups,
though the differences were not found to be statistically
significant. A couple of studies during the past few years
have reported that common variants of Gc are genetic
determinants of serum levels of 25(OH)D in Chinese
populations, and Gc 2-2 had the lowest serum
concentration of this metabolite.21,22 In our study, too, Gc
2-2 group had the lowest mean concentration of 25(OH)D.
How the Gc variant allele could be related to T2DM is
unclear. Lifelong low levels of vitamin D among carriers of
variant allele may have an adverse effect on health,
making them more vulnerable to external risk factors.23
T2DM is a multi-factorial disease and its
aetiopathogenesis could include not only genetic factors
(such as Gc genotypes) but a host of nutritional and
environmental factors as well.24 Genome-wide
association studies have revealed more than 60 gene loci
in which variants have been found to be associated with
T2DM.25 We suggest that Gc gene variants also appear to
have a role in T2DM in Pakistani population along with 6
novel T2DM susceptibility loci found in South Asian
population.26 On the basis of our data, it is conjectured
that individuals with Gc 1-2 genotype in Pakistani
population are more susceptible to the action of classical
risk factors for T2DM, such as malnutrition, obesity,
dyslipidaemia, stress, smoking, inflammation, age,
gender, impaired glucose tolerance and physical
inactivity,6,24 making them more prone to developing this
disease. 
There are quite a few limitations of this study. We
measured 25(OH)D by an immunoassay-based method
which is less sensitive than the high-performance liquid
chromatography(HPLC) and liquid chromatography-mass
spectrometry (LC-MS) or MS methods. Moreover, the
participants included in this study were mostly from
urban areas and therefore the results might not be
generalised.
Despite these limitations, the study had a reasonable
sample size to investigate the relationship of Gc
genotypes and T2DM. Moreover, matching of cases with
controls for gender and age (within 5 years) at the time of
recruitment of study participants is a major strength of
this study as it eliminated the influence of 2 confounders.
However, more data involving cases and controls from
both rural and urban areas in all the 4 provinces of the
country would be required to obtain conclusive evidence
regarding the role of Gc polymorphism and T2DM in
Pakistani population.
Conclusion
An association was found between Gc 1-2 genotype of
VDBP gene and risk of T2DM in a Pakistani population.
Hypovitaminosis D appeared to have no relationship with
T2DM.
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